ArticleAN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS
ArticleAN INSIGHT ON MEDICINAL ATTRIBUTES OF PHTHALAZINE SCAFFOLD, WITH A FOCUS ON THEIR ANTICANCER PROPERTIES AS VEGFR-2 INHIBITORS
ArticleREVIEW ON THE SIGNIFICANCE OF PYRIMIDINE DERIVATIVES AS POTENT ANTI-ANGIOGENIC VEGFR-2 INHIBITORS
ArticleREVIEW ON THE SIGNIFICANCE OF PYRIMIDINE DERIVATIVES AS POTENT ANTI-ANGIOGENIC VEGFR-2 INHIBITORS
ArticleMolecular Docking Approach of Some Quinoxaline Derivatives as Anticancer Agents Targeting VEGFR-2.
ArticleMolecular Docking Approach of Some Quinoxaline Derivatives as Anticancer Agents Targeting VEGFR-2.
ArticleSynthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.
ArticleSynthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.
ArticleEXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS
ArticleEXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS
ArticleSynthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR
ArticleSynthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR